MP

Madan Pal Singh

Active Director Director DIN 05271035
DIN 05271035 First appointment May 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2012
Shareholding value •••• Premium profile

About Madan Pal Singh

Data last updated:

Madan Pal Singh is a Director at Avanscure Lifesciences Private Limited (since 2012). The company operates in Pharma. Avanscure Lifesciences Private Limited reported revenue of ₹38.07 Cr (FY 2025).

DIN 05271035
Primary Designation Director
Industry Pharma
First Appointment 07 May 2012
Oldest Company Age 14 yrs
Largest company Avanscure Lifesciences Private Limited · ₹38.07 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 May 20122012₹38.07 Cr (FY 2025)Active

Board colleagues of Madan Pal Singh

NameDINCompanyDesignation
Gagan Jot Singh05271026Avanscure Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avanscure Lifesciences Private Limited
Premium access

Shareholding and investment profile for Madan Pal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madan Pal Singh

Madan Pal Singh currently holds 1 directorship: Avanscure Lifesciences Private Limited (Director, since 07 May 2012, revenue ₹38.07 Cr (FY 2025)).

Madan Pal Singh was first appointed on 07 May 2012 as Director at Avanscure Lifesciences Private Limited.

The current boards of Madan Pal Singh's companies include Gagan Jot Singh (Avanscure Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available